Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors related to CSII compliance.

O Ronsin1, M F Jannot-Lamotte, P Vague

  • 1University hospital Timone, Marseille, France. olivia.ronsin@wanadoo.fr

Diabetes & Metabolism
|April 2, 2005
PubMed
Summary

Continuous subcutaneous insulin infusion (CSII) effectively reduces glucose fluctuations in type 1 diabetes. However, this study found no specific predictive factors for patients discontinuing CSII therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation of perovskite thin layer crystallization with varying evaporation rates.

Materials horizons·2024
Same author

Environmental Nanoparticle-Induced Toughening and Pinning of a Growing Crack in a Biopolymer Hydrogel.

Physical review letters·2019
Same author

Preferential hydration fully controls the renaturation dynamics of collagen in water-glycerol solvents.

The European physical journal. E, Soft matter·2017
Same author

Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy.

Diabetes, obesity & metabolism·2016
Same author

Glass-like dynamics of the strain-induced coil/helix transition on a permanent polymer network.

The Journal of chemical physics·2016
Same author

Two-step build-up of a thermoreversible polymer network: From early local to late collective dynamics.

Physical review. E, Statistical, nonlinear, and soft matter physics·2015

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Diabetes Management

Background:

  • Continuous subcutaneous insulin infusion (CSII) is recognized for improving metabolic control and reducing glycemic variability in type 1 diabetes.
  • Despite its benefits, a significant number of patients discontinue CSII therapy, necessitating an understanding of associated factors.

Purpose of the Study:

  • To investigate the factors contributing to the discontinuation of continuous subcutaneous insulin infusion (CSII) in patients with type 1 diabetes.
  • To identify any predictive indicators for CSII cessation.

Main Methods:

  • A cohort of 70 type 1 diabetic patients initiating CSII between April 2000 and April 2002 were analyzed.
  • Clinical data were collected and patients were followed for up to two years to document CSII discontinuation.

Main Results:

  • Eighteen patients (25.7%) discontinued CSII after an average of 235 days.
  • Primary reasons for discontinuation included patient decision (10), end of pregnancy (4), needle site infections (3), and lack of compliance (1).
  • No statistically significant differences were observed in age, diabetes duration, HbA1c, or hypoglycemia frequency between those who continued and discontinued CSII.

Conclusions:

  • The study could not identify any specific predictive factors for the discontinuation of CSII in type 1 diabetic patients.
  • While trends suggested higher discontinuation rates among pregnant women, those attending hospital visits, and individuals with lower educational levels, these were not statistically significant.

Related Experiment Videos